PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Zytiga, Ajovy among latest SMC decisions

The Scottish Medicines Consortium (SMC) has released its latest round of medicines approved for use on NHS Scotland, approving drugs for prostate cancer, primary pro...
Continue Reading →
News

Brussels Airport starts 2020 with a reinforced cargo team

At the end of 2019 Brussels Airport decided to significantly expand and strengthen its cargo team. Cargo was already an import cornerstone in the strategy and develo...
Continue Reading →
News

NHS migraine kit to prevent ‘thousands’ of hospital stays

The NHS has announced a new “Headache and Migraine Toolkit”, with hopes of avoiding up to 16,500 emergency hospital admissions every year. The organisation says th...
Continue Reading →
News

Could AI help detect breast cancer?

In new research from The National Institute for Health Research (NIHR), an artificial intelligence algorithm has been shown to be as effective as human radiologists ...
Continue Reading →
News

Sandoz opens new UK HQ

Novartis’ Sandoz division has announced a new UK headquarters based in Camberley, Surrey. The global leader in generics and biosimilars announced that it has opene...
Continue Reading →
News

New NHS DNA test could ‘rapidly diagnose’ rare illnesses in babies

A new form of DNA testing could rapidly diagnose rare diseases in critically ill babies and children, potentially benefitting up to 700 patients each year. The new...
Continue Reading →
News

MHRA updates Dysport license to include upper limb spasticity in children

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Ipsen a licence update for Dysport (abobotulinumtoxinA), extending the use of the drug to ...
Continue Reading →
News

Improve brand and batch number recording, urge drug safety professionals

New research from the UK’s Drug Safety Research Unit (DSRU) has found that hospital pharmacists, doctors and nurses only recorded batch numbers for biologic medicine...
Continue Reading →
News

Merck’s Bavencio hits targets in bladder cancer interim analysis

New data released from the Phase III JAVELIN Bladder 100 study in previously untreated locally advanced or metastatic urothelial carcinoma (UC) has shown that Bavenc...
Continue Reading →
News

Keytruda misses key lung cancer survival endpoint

Recent data from the Phase III KEYNOTE-604 trial has revealed mixed results for MSD’s Keytruda (pembrolizumab). The cancer blockbuster in combination with chemothe...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026